Cytomegalovirus infection and atherosclerosis

Central European Journal of Public Health

Volumn 5, Issue 3, 1997, Pages 99-106

  Adam, E ^a   Melnick, J L ^a   DeBakey, M E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Cytomegalovirus latency; Heart transplantation; Marek's disease virus; Persistent infection; Smooth muscle cells

Indexed keywords

VIRUS ANTIBODY;

ANIMAL; ARTERIOSCLEROSIS; BIRD DISEASE; BLOOD; CYTOMEGALIC INCLUSION BODY DISEASE; CYTOMEGALOVIRUS; DISEASE MODEL; EPIDEMIOLOGY; HEART TRANSPLANTATION; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; IMMUNOLOGY; REVIEW; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; ARTERIOSCLEROSIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; HEART TRANSPLANTATION; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; MAREK DISEASE; SEROEPIDEMIOLOGIC STUDIES;

EID: 0031216709     PISSN: 12107778     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Ross, R.: The pathogenesis of atherosclerosis. An update. N. Engl. J. Med. 314, 1986, 488-500.
2. Melnick, J. L., Adam, E., DeBakey, M. E.: Possible role of cytomegalovirus in atherogenesis. J. Amer. med. Assoc. 263, 1990, 2204-2207.
3. Benditt, E. P., Benditt, J. M.: Evidence for a monoclonal origin of human atherosclerotic plaques. Proc. natl. Acad. Sci. USA. 70, 1973, 1753-1756.
4. Fabricant, C. G., Fabricant, J., Litrenta, M. M., Minick, C. R.: Virus induced atherosclerosis. J. exp. Med. 148, 1978, 335-340.
5. Ross, R.: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 1993, 801-809.
6. Penn, A., Garte, S. J., Warren, L., Nesta, D., Minick, B.: Transforming gene in atherosclerotic plaque DNA. Proc. natl. Acad. Sci. USA. 83, 1986, 7951-7955.
7. Frothingham, C.: The relation between acute infectious diseases and arterial lesions. Arch. intern. Med. 8, 1911, 153-162.
8. Ophuls, W.: Arteriosclerosis and cardiovascular disease: their relation to infectious diseases. J. Amer. med. Assoc. 76, 1921, 700-701.
9. Burch, G. E.: Viruses and arteriosclerosis: Amer. Heart J. 87, 1974, 407-412.
10. Paterson, J., Cottral, G. E.: Experimental coronary sclerosis. III: Lymphomatosis as a cause of coronary sclerosis in chickens. Arch. Pathol. 49, 1950, 699.
11. Fabricant, C. G., Krook, L., Gillespie, J. H.: Virus induced cholesterol crystals. Science 181, 1973, 566-567.
12. Fabricant, C. G., Fabricant, J., Litrenta, M. M., Minick, C. R.: Virus induced atherosclerosis. J. exp. Med. 148, 1978, 335-340.
13. Minick, C. R., Fabricant, C. G., Fabricant, J., Litrentq, M. M.: Atherosclerosis induced by infection with herpesviruses. Amer. J. Pathol. 96, 1979, 676-706.
14. Fabricant, C. G., Fabricant, J., Minick, C. R., Litrenta, M. M.: Herpesvirus-induced atherosclerosis in chickens. Fed. Proc. 42, 1983, 2476-2479.
15. Fabricant, C. G., Fabricant, J.: Marek's disease virus-induced atherosclerosis and evidence for a herpesvirus role in the human vascular disease. In: Calnek, B. W., Spencer, J. L., eds. International Symposium on Marek's Disease, 1984 Proceedings. Amer. Assoc. Avian Pathologists Publication, Philadelphia, 1985, 17.
16. Hajaar, D. P., Fabricant, C. G., Minick, C. R., Fabricant, J.: Virus-induced atherosclerosis: Herpesvirus infection alters aortic cholesterol metabolism and accumulation. Amer. J. Pathol. 122, 1986, 62-70.
17. Shin, J. C. H., Pullman, E. P., Jao, K. J.: Genetic selection, general characterization, and history of atherosclerosis-susceptible and -resistant Japanese quail. Atherosclerosis 49, 1983, 41-53.
18. Lemstrom, K., Persoons, M., Bruggeman, C., Ustinov, J., Lautenschlager, I., Hayry, P.: Cytomegalovirus infection enhances allograft arteriosclerosis in the rat. Transplantation Proc. 25, 1993, 1406-1407.
19. Lemstrom, K. B., Bruning, J. M., Bruggeman, C. A., Lautenschlager, I. T., Hayry, P. J.: Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts. J. clin. Invest. 92, 1993, 549-558.
20. Persoons, M. C., Daemen, M. J., Bruning, J. H., Bruggeman, C. A.: Active Cytomegalovirus infection of arterial smooth muscle cells in immunocompromised rats. A clue to herpesvirus-associated atherogenesis? Circul. Res. 75, 1994, 214-220.
21. Rapp, F.: Persistence and transmission of Cytomegalovirus. In: Fraenkel-Conrat, Wagner, Comprehensive virology. Plenum Press, New York, vol. 16, p. 34.
22. Jordan, M. C.: Latent infection and the elusive cytomegalovirus. Rev. infect. Dis. 5, 1983, 205-215.
23. Roche, I. K., Cheung, K. S., Boldogh, I., Huang, E-S., Lang, D. J.: Cytomegalovirus: detection in human colonic and circulating mononuclear cells in association with gastrointestinal disease. Int. J. Cancer 27, 1981, 659-668.
24. Myerson, D., Hackman, R. C., Nelson, J. A., Ward, D. C., McDougall, J. K.: Widespread presence of histologically occult cytomegalovirus. Hum. Pathol. 15, 1984, 430-439.
25. Tumilowicz, J. J., Gawlik, M. E., Powell, B. B., Trentin, J. J.: Replication of cytomegalovirus in human arterial smooth muscle cells. J. Virol. 56, 1985, 839-845.
26. Albrecht, T., Rapp, F.: Malignant transformation of hamster embryo fibroblasts following exposure to ultraviolet irradiated human cytomegalovirus. Virology 55, 1973, 53-61.
27. Geder, L., Lausch, R. N., O'Neill, F. J., Rapp, F.: Oncogenic transformation of human embryo lung cells by human cytomegalovirus. Science 192, 1976, 1134-1137.
28. Albrecht, T., Nachtigal, M., St. Geor, S. C., Rapp, F.: Induction of cellular DNA synthesis and increased mitotic activity in Syrian hamster embryo cells abortively infected with human cytomegalovirus. J. Gen. Virol. 30, 1976, 167-177.
29. De Marchi, J. M., Kaplan, A. S.: Role of defective cytomegalovirus particles in the induction of host cell DNA synthesis. Virology, 82, 1977, 93-99.
30. Sullivan, J. L., Hanshaw, J. B.: Human cytomegalovirus infections. In: Glaser, Gotlieb-Stematsky, eds. Human herpesvirus infections, Marcel Dekker, New York, 1982, 27.
31. Smiley, M. L., Mar, E-C., Huang, E-S.: Cytomegalovirus infection and viral-induced transformation of human endothelial cells. J. med. Virol. 25, 1988, 213-226.
32. Span, A. H. M., van Boven, C. P. A., Bruggeman, C. A.: The effect of cytomegalovirus infection on the adherence of polymorphonuclear leucocytes to endothelial cells. Eur. J. clin. Invest. 19, 1989, 542-548.
33. Visser, M. R., Jacob, H. S., Goodman, J. L., McCarthy, J. B., Furcht, L. T., Vercellotti, G. M.: Granulocyte-mediated injury to herpes simplex virus-infected human endothelium. Lab. Invest. 60, 1989, 296-304.
34. Key, N. S., Vercellotti, G. M., Winkelmann, J. C., Moldow, C. F., Goodman, J. L., Esmon, N. L., Esmon, C. T., Jacob, H. S.: Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression. Proc. natl. Acad. Sci. USA, 87, 1990, 7095-7099.
35. Bruggeman, C. A., van Dam-Mieras, M. C. E.: The possible role of cytomegalovirus in atherogenesis. In: Melnick, J. L. ed. Prog. Med. Virol. 1991, 38, 26.
36. Etingin, O. R., Silverstein, R. L., Hajjar, D. P.: Identification of a monocyte receptor on herpesvirus-infected endothelial cells. Proc. natl. Acad. Sci. USA, 88, 1991, 7200-7203.
37. Melnick, J. L., Petrie, B. L., Dreesman, G. R., Burek, J., McCollum, C. H., DeBakey, M. E.: Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet ii, 1983, 644-647.
38. Petrie, B. L., Melnick, J. L., Adam, E., Burek, J., McCollum, C. H., DeBakey, M. E.: Nucleic acid sequences of cytomegalovirus in cells cultured from human arterial tissue. J. infect. Dis. 55, 1987, 158-159.
39. Benditt, E. P., Barrett, T., McDougall, J. K.: Viruses in the etiology of atherosclerosis. Proc. natl. Acad Sci. USA, 80, 1983, 6386-6389.
40. Yamashiroya, H. M., Ghoch, L., Yang, R., Robertson, A. L. Jr.: Herpesviridae in the coronary arteries and aorta of young trauma victims. Amer. J. Pathol. 130, 1988, 71-79.
41. Hendrix, M. G. R., Dormans, P. H. J., Kitslaar, P., Bosman, F., Bruggeman, C. A.: The presence of cytomegalovirus nucleic acids in arterial walls of atherosclerotic and non-atherosclerotic patients. Amer. J. Pathol. 134, 1989, 23-28.
42. Hendrix, M. G. R., Salimans, M. M. M., van Boven, C. P. A., Bruggeman, C. A.: High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Amer. J. Pathol. 136, 1990, 23-28.
43. Jahan, N., Razzaque, A. R., Brady, J., Rosenthal, L. J.:The human cytomegalovirus mtr II colinear region in strain Tanaka is transformation defective. J. Virol. 63, 1989, 2866-2869.
44. Melnick, J. L., Hu, C., Burek, J., Adam, E., DeBakey, M. E.: Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J. med. Virol. 42, 1994, 170-174.
45. Tanaka, S., Toh, Y., Mori, R., Komori, K., Okadome, K., Sugimachi, K.: Possible role of cytomegalovirus in the pathogenesis of inflammatory aortic disease. J. vasc. Surg. 16, 1992, 274.
46. Adam, E., Melnick, J. L., Probstfield, J. L., Petrie, B. L., Burek, J., Bailey, K. R., McCollum, C. H., DeBakey, M. E.: High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet ii, 1987, 291-293.
47. The ARIC investigators. Atherosclerosis Risk in Communities (ARIC) Study, Design Aid objectives. Amer. J. Epidemiol. 129, 1989, 687-702.
48. Heiss, G., Sharrett, A. R., Barnes, R., Chambless, L. E., Szklo, M., Alzola, C.: Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Amer. J. Epidemiol. 134, 1991, 250-256.
49. Sorlie, P. D., Adam, E., Melnick, S. L., Folsom, A., Skelton, T., Chambless, L. E., Barnes, R., Melnick, J. L.: Cytomegalovirus/herpesvirus and carotid atherosclerosis. The ARIC Study. J. med. Virol. 42, 1994, 33-37.
50. Nieto, F. J., Adam, E., Sorlie, P., Farzadegan, H., Melnick, J. L., Comstock, G. W., Szklo, M.: Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation 94, 1996, 922-927.
51. Wreghitt, T. G., Hakim, M., Bray, J. J., Kucia, S., Cory-Pearce, R., Wallwork, J., English, T. A.: A detailed study of cytomegalovirus infections in the first 160 heart and heart/lung transplant recipients at Papworth Hospital, Cambridge, England. Transplant. Proc. XIX, 1987, 2495-2496.
52. Lowry, R. W., Adam, E., Hu, C., Kleiman, N. S., Cocanougher, B., Windsor, N., Bitar, J. N., Melnick, J. L., Young, J. B.: What are the implications of cardiac infection with cytomegalovirus before heart transplantation? J. Heart Lung Transplant. 13, 1994, 122-128.
53. Min, K. W., Wickemeyer, W. J., Chandran, P., Shadur, C. A., Gervich, D., Phillips, S. J., Zeff, R. H., Song, J.: Fatal cytomegalovirus infection and coronary arterial thromboses after heart transplantation: a case report. J. Heart Transplant. 6, 1987, 100-105.
54. Loebe, M., Schuler, S., Zais, O., Warnecke, H., Hetzer, R.: The role of cytomegalovirus infection for the development of coronary artery disease (CAD) in the transplanted heart (abstr.). J. Heart Transplant. 8, 1989, 104.
55. Loebe, M., Schuler, S., Spiegelsberger, S., Warnecke, H., Fleck, E., Hetzer, R.: Cytomegalievirus-Infektion und Koronarsklerose nach Herz-Transplantation. Dtsch med. Wschr. 115, 1990, 1266-1269.
56. Grattan, M. T., Moreno-Cabral, C. E., Starnes, V. A., Oyer, P., Stinson, E. B., Shumway, N. E.: Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. J. Amer. med. Assoc. 261, 1989, 3561-3566.
57. Grattan, M. T.: Accelerated graft atherosclerosis following cardiac transplantation : clinical perspectives. Clin. Cardiol. 14(suppl. ii), 1991, 16-20.
58. McDonald, J. L., Rector, R. S., Braunlin, E. A., Kubo, S. H., Olivari, M. T.: Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Amer. J. Cardiol. 64, 19879, 359.
59. Pahl, E., Fricker, F. J., Armitage, J., Griffith, B. P., Taylor, S., Uretsky, B. F., Beerman, L. B., Zuberbuhler, J. R.: Coronary arteriosclerosis in pediatric heart transplant survivors: limitation of long-term survival. J Pediat. 116, 1990, 177-183
60. Wu, T-C., Hruban, R. H., Ambinder, R. F., Pizzorno, M., Cameron, D. E., Baumgartner, W. A., Reitz, B. A., Hayward, G. S., Hutchins, G. M.:Demonstration of cytomegalovirus nucleic acids in the coronary arteries of transplanted hearts. Amer. J. Pathol. 140, 1992, 739-747.
61. Fukushima, M., Gundry, S. R., Razzouk, A. J., Bailey, L. L.: Cytomegalovirus infection in pediatric heart transplantation. Transplant. Proc. 25, 1993, 1423-1425.
62. Dummer, S., Lee, A., Breinig, M. K., Kormos, R., Ho, M., Griffith, B.: Investigation of cytomegalovirus infection as a risk factor for coronary atherosclerosis in the explanted hearts of patients undergoing heart transplantation. J. med. Virol. 44, 1994, 305-309.
63. Pober, J. S.: Immunologic basis of cardiovascular disease: an overview. Clin. Cardiol. 14(suppl ii), 1994, 1-2.
64. Spier, E., Modali, R., Huang, E-S., Leon, M. B., Shawl, F., Finkel, T., Epstein, S. E.: Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 165, 1994, 391-394.
65. Zhou, Y. F., Leon, M. B., Waclawiw, M. A., Popma, J. J., Yu, Z. X., Finkel, T., Epstein, S. F.: Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. New Engl. J. Med. 335, 1996, 624-630.